Clinilabs Drug Development Corporation and Verified Clinical Trials (VCT) are pleased to announce the launch of Assure Screen, a pre-screening program for clinical trial participants that helps to reduce screen failure rates and the costs associated with screening study candidates. The Assure Screen program enables investigators to obtain informed consent from subjects to participate [...]
Clinilabs Drug Development Corporation is pleased to announce that it has established two new regional offices in 2017. An office has been established in San Diego, California in order to accommodate the increasing number of West Coast sponsors now working with the company. The office provides a convenient location for its regional staff, and enables [...]
Clinilabs Drug Development Corporation is pleased to announce that it has established a 6-bed epilepsy monitoring unit at its New York City facility. The facility, which boasts a 50-bed inpatient capacity for clinical studies, offers sponsors and subjects six comfortable, private rooms for video EEG monitoring. Each room is equipped with premium bedding, with beds [...]
At this year’s CNS Summit, held in Boca Raton, Florida November 1 – 4 2017, attendees participated in a panel discussion that considered the characteristics that investigator sites will have in the future. Many of the panelists contemplated the role that digital technology might have on the way that clinical trial sites will function. It [...]
